RYNEZE (Ryneze 8 MG-2.5 MG)
Generic Name: chlorpheniramine/methscopolamine
Pill with imprint RYNEZE is Blue, Capsule-shape and has been identified as Ryneze 8 MG-2.5 MG. It is supplied by SJ Pharmaceuticals LLC.
Ryneze is used in the treatment of rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Ryneze 8 MG-2.5 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for RYNEZE
Ryneze
- Generic Name:
- chlorpheniramine/methscopolamine
- Imprint:
- RYNEZE
- Strength:
- 8 MG-2.5 MG
- Color:
- Blue
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- SJ Pharmaceuticals LLC
- National Drug Code (NDC):
- 45985-0659
More about Ryneze (chlorpheniramine / methscopolamine)
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
